Academic Editor: Enrique Hernandez
Objective: The majority of advanced ovarian cancer (OC) patients do not
fully respond to systemic chemotherapy, thus complete cytoreduction can not be
achieved in such cases. Pressurized intraperitoneal aerosol chemotherapy (PIPAC)
has been suggested as an alternative approach for these women. Our study aimed to
review the literature regarding the application of pressurized intraperitoneal
aerosol chemotherapy (PIPAC) in OC patients with peritoneal carcinomatosis (PC).
Data source: Articles in the English language were searched in PubMed.
Search terms included “PIPAC” and “ovarian cancer”. Methods of study
selection: The authors evaluated all studies presenting an application of
pressurised intraperitoneal aerosol chemotherapy (PIPAC) on ovarian cancer
patients. The published guidelines for Systematic Reviews and Meta-analyses
(PRISMA) were followed in the present systematic review which was performed based
on the authors’ predetermined inclusion criteria. Tabulation: Table